The researchers engineered a completely synthetic, production-ready molecule that straitjackets the crucial SARS-CoV-2 machinery that allows the virus to infect our cells. In an aerosol formulation they tested, these molecules could be self-administered with a nasal spray or inhaler. Read the full story on the preprint server bioRxiv

In response to the novel coronavirus pandemic, policy makers need to make decisions quickly. Unfortunately, they are missing powerful, flexible analytical tools to do this. Dr. Getz and Dr. Salter designed a new web app called NMB-DASA, to evaluate the impact of different parameter values and drivers on incidence rates, including, surveillance, social distancing (rate and efficacy), social relaxation, quarantining

Through groundbreaking studies on dengue and efforts to build scientific infrastructure in Latin America, the University of California, Berkeley, professor has bridged research with its benefits to society. Read the article on the scientist website

On January 10th, 2020, Dr. Hailing Jin stood in Li Ka Shing at the 12th Annual CEND Symposium, presenting her work on small RNA trafficking between plants and fungal pathogens. Through her research, she reported, she has found that pathogen gene-targeting RNAs represent a new generation of fungicides that are durable and eco-friendly. Her talk

Covid Catalyst Update

Wednesday, 13 May 2020 by

COVID Catalyst Awardees Announced!   Congratulations to our Covid Catalyst awardees for being selected for bridge funding for their high-risk, innovative, and important research on the Covid-19 pandemic. Awardees by institution: UC Berkeley Kunxin Luo – High affinity soluble ACE2 decoy receptor approach for Covid-19             Russell Vance –  Targeting the inflammasome

CEND investigator Dr. Eva Harris and collaborators from the National Autonomous University of Nicaragua, Emory University, University of North Carolina at Chapel Hill, UC Berkeley, published their serologic surveillance findings of maternal Zika infection on Leon, Nicaragua, which found that 20% of pregnant women were infected at the peace of the epidemic. Read the full

CEND Hackathon Winners Announced

Monday, 30 March 2020 by

On March 25th, at 2 PM PST, over 80 participants from around the world – ranging from Berkeley to New York City to France and India – hopped on a Zoom call to participate in the 2020 CEND COVID19 Hackathon, to address many issues coming from the pandemic. Some participants came with nearly fully-formed ideas,

UC Berkeley Drug Discovery Center

Saturday, 28 March 2020 by

Welcome to the the UC Berkeley Drug Discovery Center. We provide state-of-the-art technology, and scientific expertise in assay development, screening, target ID, drug discovery through preclinical development and IND submission. We are constantly growing our library, currently at ~120,000 compounds and focused on diverse, drug-like molecules including approved compounds and bio-actives. We uniquely combine academic

Bay Area Lab Facilities and Resources

Monday, 16 March 2020 by

Current Funding Opportunities

Monday, 16 March 2020 by

Government fundings, alongside philanthropic and private sector support is critical to support researchers’ efforts to combat COVID-19 pandemic. An analysis made by Devex between Jan. 1 and April 5 shows that 569 initiatives worth $10.9 trillion were already initiated. To help researchers identify COVID-19 funding opportunities, we have created and maintained a list of COVID-19

TOP UA-36873340-1